Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination regimen used ...
Newsday Investigates Explore the data: Racial disparities in police use of force persist Newsday analyzed police use-of-force statistics between 2021 and 2024 that were reported to the state by 358 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback